Skip to search formSkip to main contentSkip to account menu

TAS 301

Known as: TAS-301, TAS301 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Indoles

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
Highly Stabilized Amorphous 3-bis(4-Methoxyphenyl)methylene-2-indolinone (TAS-301) in Melt-Adsorbed Products with Silicate Compounds
Abstract 3-Bis(4-Methoxyphenyl)methylene-2-indolinone (TAS-301) is a poorly water-soluble drug showing low oral bioavailability… 
2001
2001
TAS-301, a New Synthetic Inhibitor of Neointimal Thickening after Balloon Injury, Inhibits Calcium-Dependent Signal Transduction and Cytoskeletal Reorganization
We previously demonstrated that a recently synthesized drug, TAS-301 [3-bis(4-methoxyphenyl)methylene-2-indolinone], inhibited… 
2000
2000
Inhibitory effect of TAS-301, a new synthesized constrictive remodeling regulator, on renarrowing after balloon overstretch injury of porcine coronary artery.
The purpose of this study was to determine the efficacy and the possible mechanism of action of a recently synthesized drug, TAS… 
2000
2000
TAS-301 blocks receptor-operated calcium influx and inhibits rat vascular smooth muscle cell proliferation induced by basic fibroblast growth factor and platelet-derived growth factor.
The purpose of this study was to determine the effect of a recently synthesized drug, TAS-301 [3-bis(4-methoxyphenyl)methylene-2… 
1997
1997
3.P.330 New therapeutic possibility with TAS-301 for restonosis by regulating vascular remodeling: Insight from porcine coronary stenosis model
1997
1997
3.P.327 Newly synthesized TAS-301, by regulating the migration process, reduces the neointimal thickening after balloon injury in rats
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)